Professional Experience:
2003-2006 Cardiothoracic Surgeon, University of Utah, Salt Lake City, UT
2003-2010 Cardiothoracic Surgeon, George E. Wahlen VA, Salt Lake City, UT
2011-2014 Cardiothoracic Surgeon & Interventional Cardiologist,
Director, Heart Valve Clinic and Transcatheter Valve Therapies
Dean & St. Mary’s Cardiac Center, Madison, WI
2015-Present Cardiothoracic Surgeon, Memorial Hospital,
University of Colorado Health System, Colorado Springs, CO
2017-Present Founder and Director, Park City Performance Medicine, Park City, UT
Education and Training:
1987 La Salle University, Philadelphia, PA (BA)
1993 Hahnemann University School of Medicine, Philadelphia, PA (MD)
1993-1999 Intern/Resident, General Surgery, Hahnemann University Hospital, Philadelphia, PA
1995-1998 Research Fellow, The Center for Gene Therapy, Philadelphia, PA
1999-2001 Resident, General Surgery, University of Utah, Salt Lake City, UT
2001-2003 Fellow, Cardiothoracic Surgery, University of Utah
2010-2011 Fellow, Interventional Cardiology, TAVR & Hybrid Cardiac Surgery, NYP-Columbia University Medical Center, New York, NY
Board Certification:
1994 National Board of Medical Examiners Certificate no. 431025
2002 American Board of Surgery Certificate no. 47315
2004 American Board of Thoracic Surgery Certificate no. 6981 (recert 2013)
Licensure & DEA:
Colorado: Physician Medical Doctor License no. DR.0056019
New York: Medicine & Surgery License no. 257447 (inactive)
Pennsylvania: Physician & Surgeon License no. MD-056956-L (inactive)
Utah: Physician & Surgeon License no. 4829190-1205
Wisconsin: Medicine & Surgery License no. 56363-20
DEA Utah Registration No. FR6613574
DEA Colorado Registration No. BR7115531
Industry Experience:
2003-2006 Co-Founder, Xelas Therapeutics, Salt Lake City, UT
2004-2010 Scientific Advisory Board (SAB), Bacterin, Inc. Belgrade, MT
2005-present SAB, Medisurg Research and Management Corporation, Norristown, PA
2005-2010 Consultant, WorldHeart Corporation, Oakland, CA
2006-2008 Consultant, Glycosan Biosystems, Salt Lake City, UT
2006-2008 Consultant, Allocure, Salt Lake City, UT
2007-2008 Medical Director, University of Utah Cord Blood Program
2007-2009 Co-Director, Center of Excellence for Cell Therapy and Regenerative Medicine
2007-2009 Co-Founder, Dycera, Salt Lake City, UT
2007-2010 Co-Founder & Medical Director, University of Utah Cell Therapy Facility
2007-2011 Medical Director, Creating Wellness, Mahwah, NJ
2007-2015 Member, Park City Angel Network, Park City, UT
2007-present Principal, R5 BioSystems, Park City, UT
2013-present Board Member, SymbioCellTech, Salt Lake City, UT
2014-present Co-Founder, Transit Scientific, Park City, UT
Additional Certification:
1993 – 2001 Advanced Trauma Life Support
1993 – Present Basic Cardiac Life Support
1993 – Present Advanced Cardiac Life Support
“Care and Utilization of Animals in Biomedical Research,” Allegheny University of the Health Sciences, IACUC, Certification, August 14, 1995. (Re-certification IACUC 101, March 28, 2009)
Focused Abdominal Sonogram for Trauma (FAST), University of Utah School of Medicine, Salt Lake City, UT. Certification, January 15, 2000.
Recognizing and Reporting Child Abuse, Maltreatment, and Neglect-New York State,
Certificate # MSSNNY9525, April 29, 2010.
Infection Control Certification for New York State Licensure (2010),
Certification ID: CRT-1055700. May 18, 2010.
Honors and Awards:
1980 Eagle Scout
1986-1987 Alpha Epsilon Delta Premedical Honors Society
Vice-President, La Salle University
1987 General University Honors
Honors Program, La Salle University 1983-1987
1993 Distinguished Performance Award in Neoplastic Diseases
Hahnemann University School of Medicine
2005 Samson Resident Prize Essay
Whitten, MG, Reiss, GR, Choi, D, Lee, M, Kim, SW, Bull, DA.
Ischemia-Inducible Gene Therapy for Myocardial Infarction.
Western Thoracic Surgery Association, Victoria, BC.
Teaching Responsibilities and Community Activities:
1989-1993 Adolescent Substance Abuse Program
Hahnemann University School of Medicine
Position: Volunteer Teacher
1998-1999 Surgical Residency Committee
Hahnemann University School of Medicine
Position: Surgical Resident Representative
2003-2008 Core Curriculum Review in Thoracic Surgery
LDS Hospital and University of Utah Divisions of
Cardiothoracic Surgery
Position: Teaching Faculty
2004-2010 Practitioner Health Committee
VA Salt Lake City Medical Center
Position: Chair
2005-2008 National Academy of Perioperative Echocardiography (NAPE)
University of Utah Department of Anesthesia
Position: Teaching Faculty
2005-2010 Research and Development Committee
VA Salt Lake City Medical Center
Position: Member (Chair 2006-2008)
2006-2008 BioDesign: Biomedical Device Innovation Program
University of Utah Department of Bioengineering
Position: Faculty-Champion
2007-2008 University of Utah Hospitals Cord Blood Program
Position: Founder and Medical Director
2007-2009 University of Utah Cell Therapy Facility
Position: Medical Director
2008 Salt Lake Community College Biotechnology Curriculum
Cell Therapy and Regenerative Medicine
Position: Visiting Faculty
2008 University of Utah Osher Lifelong Learning Curriculum
Cell Therapy and Regenerative Medicine
Position: Course Director
2009-2010 Institutional Animal Care and Use Committee (IACUC)
VA Salt Lake City Medical Center
Position: Chair
2011-12 Transcatheter Cardiovascular Therapies (TCT)
The Cardiovascular Research Foundation
Position: Teaching Faculty
Research Training:
1995-1996 Surgical Research Fellow
Department of Microbiology and Immunology, Drexel University College of Medicine, Philadelphia
Thesis topics: Intrathymic Injection as a Mechanism of Tolerance Induction without Chronic Immunosuppression in Cardiac Allografts and Xenografts
The Kinetics of Microchimerism after Cardiac Allotransplantation in the Experimental Intrathymic Pretreatment Model
Advisors: Elizabeth P. Blankenhorn, PhD, Professor Department of Microbiology and Immunology
Verdi J. DiSesa, MD, Professor, Department of Cardiothoracic Surgery
1996-1998 Doctoral Candidate & Research Fellow
The Center for Gene Therapy, Drexel University College of Medicine, Philadelphia
Thesis Topic: Mesenchymal Stem Cell Transplantation to Rescue Mammals from Lethal Conditioning and Enhance Solid Organ Tolerance
Advisor: Darwin J. Prockop, MD, PhD, Professor and Director, The Center for Gene Therapy, Member, The National Academy of Sciences
Research Support:
Completed
1996 Transplantation Immunology Educational Grant Award: $500
American Society for Transplant Physicians
1996 Immunobiology Center Pilot Project Award Award: $4,500
Hahnemann University School of Medicine
1996 House Staff Research Training Program Award Award: $4,500
Hahnemann University School of Medicine
1997 House Staff Research Training Program Award Award: $2,000
Hahnemann University School of Medicine
2003-2008 1HLO71541-01A1 PI: David A. Bull
Source: NIH/NHLBI
Title: Polymer Carrier for Ischemia-Inducible Gene Therapy
Role: Co-Investigator Award: $1.25MM
2004-2007 Western Institute for Biomedical Research (WIBR) Research Grant
Source: WIBR
Title: Stem Cell Therapy for the Treatment of Ischemic Heart Disease
Role: PI Award: $30K
2004-2008 Merit Review CLIM Award
Source: Department of Veterans Affairs
Title: Stem Cell Therapy as Adjunct to Revascularization: STAR
Role: PI Award: $925K
2005-2007 CATALYST Grant: PI: Dean Y Li
Source: University of Utah
Title: Novel Angiogenic Therapies for Ischemic Cardiomyopathy
Role: Co-Investigator Award: $200K
2006-2007 Center of Excellence Business Team Grant
Source: State of Utah Governor’s Office of Economic Development
Title: Center of Excellence for Utah Center for Cell Therapy
Role: Co-Director Award: $25K
2006-2007 Virtual Incubator Project Grant PI: Glenn Prestwich
Source: The University of Utah Research Foundation
Title: Extracellular Matrix Support of Stem Cells
Role: Co-investigator Award: $50K
2007-2009 Utah Center of Excellence Director: Kelley
Source: State of Utah Governor’s Office of Economic Development
Title: Center of Excellence for Cellular Therapy and Regenerative Medicine
Role: Co-Director Award: $125K
2008 -2010 Allocure, Inc PI: Westenfelder
Title: Phase I Clinical Trial: Prevention and Treatment of Post-operative Acute Kidney Injury with Allogeneic Mesenchymal Stem Cells in Patients Who Require On-Pump Cardiac Surgery
Role: Co-Investigator Self-Funded through Allocure, Inc
2009-2012 CBET-0932456 PI: Peattie
Source: NSF/Bioengineering
Title: Collaborative Research: Engineering an Angiogenic Cardiac Patch
Role: Co-Investigator Award: $400K
Regulatory Approvals:
FDA Investigational New Drug Application (IND)
Product: Autologous Bone Marrow Mononuclear Cells (BMNCs)
Indication: Ischemic Heart Disease
Sponsor: G. Russell Reiss, MD
Position: Sponsor-Investigator
FDA IND
Product: Autologous Bone Marrow-Derived Mesenchymal Stem Cells (MSCs)
Indication: Acute Renal Failure Post-Cardiac Surgery
Sponsor: Allocure, Inc., Salt Lake City, UT
Position: Sub-Investigator
FDA Investigational New Animal Drug Application (INAD)
Product: Allogeneic cell-based therapy to be used in insulin-dependent diabetic dogs to provide them with a physiological, in vivo source of insulin.
Indication: Canine Type 1 Diabetes
Sponsor: SymbioCellTech, LLC, Salt Lake City, UT
Position: Pre-Clinical and Clinical Regulatory Advisor
Patents:
“Stromal Cell Use” (99-320): Utilization and Application of Bone Marrow Stromal Cells to Enhance Hematopoiesis in a Mammal. Inventors: Prockop, DJ; Reiss GR; Langell JT (US Patent Applications 20020058025, 20040208861, 20080102058)
Systems and Methods for Classifying and Screening Biological Materials for Use in Therapeutics and/or Research Purposes. Inventors: Reiss, GR, Kelley, LL.
(USPTO application 2009)
Lectures and Symposiums:
Stem Cells for Ischemic Heart Disease, The Utah Center for Advanced Imaging Research (UCAIR) Seminar Series, University of Utah, Salt Lake City, Utah April 14, 2005.
Adult Stem Cells: Regulatory Issues and Cardiac Applications, The 2nd Annual Bacterin Scientific Retreat, Montana State University, Bozeman, MT, September 10, 2005.
Stem Cells for Ischemic Heart Disease. How close are we in the U.S? Cardiovascular Grand Rounds, The LDS Hospital, Salt Lake City, Utah October 5, 2005.
Clinical Application of Adult Derived Stem Cells. BioInterface 2005, Surface and Biomaterials Foundation, Minneapolis MN, October 26, 2005.
Cell Therapy in the Open Heart. International Society for Cellular Therapy 6th Annual Somatic Cell Therapy Symposium, Bethesda, MD, September 25, 2006.
The Future of Stem Cells in Medicine. Senator Orrin Hatch’s 22nd Annual Utah Women’s Conference, Salt Lake City, UT, October 30, 2006.
Regenerative Medicine in the Operating Room. Association for Operating Room Nurses (AORN) local Chapter Meeting, Salt Lake City, UT, April 10, 2007.
Umbilical Cord Blood Banking and Novel Stem Cell Therapies at the U, Park City Institute, Park City, UT, November 15, 2007.
Cell Therapy and Regenerative Medicine. AORN National Meeting, Salt Lake City, UT, September 25, 2008.
20th Annual Cardiovascular Nurse and Technologist Symposium. Transcatheter Cardiovascular Therapies (TCT) San Francisco, CA, November 7, 2011. Moderator.
Innovative Surgical Techniques and Technologies: Valvular Heart Disease Session, TCT, San Francisco, CA, November 9, 2011. Moderator.
New Paradigms in the Management of Valvular Heart Disease. St. Mary’s Hospital Grand Rounds, Madison, Wisconsin, April 5, 2012.
Management of Iliac Vascular Complications in TAVR. Wisconsin Valve Symposium: Spotlighting Transcatheter Aortic Valve Replacement (TAVR), University of Wisconsin, Madison WI, September 20, 2013. Presenter and Moderator.
National and International Presentations:
1. - Shen Z, Muhiuddin M, Yokoyama H, Reiss GR, DiSesa VJ. “Tolerance to Experimental Cardiac Allografts Requires a Time Lag Between Intrathymic Pretreatment and Transplantation.” The Association for Academic Surgery Annual Meeting, Minneapolis, MN, 1995.
2. - Shen Z, Muhiuddin M, Yokoyama H, Reiss GR, DiSesa VJ. “The Induction of Tolerance to an Experimental Cardiac Allograft Requires Inoculation of Class II MHC Disparate Antigens.” The Americam Association for Thoracic Surgery 76th Annual Meeting, San Diego, CA, 1996.
3. - Shen Z, Pelletier S, Muhiuddin MM, Yokoyama H, Reiss GR, DiSesa VJ. “Different Immune Effects On Cardiac Allografts and Xenografts Induced by Neonatal Intrathymic Inoculation with Allo- and Xenogeneic Antigens.” International Society of Heart & Lung Transplantation, Washington, DC, 1996.
4. - Goldstein, C, Reiss, GR, Yokoyama, H, Shen, Z, Muhiuddin MM, DiSesa, VJ. “A Clinically Applicable Intrathymic Pretreatment Regimen Produces Tolerance to Experimental Cardiac Transplants.” The American College of Surgeons 82nd Annual Clinical Congress, San Francisco, CA, 1996.
5. - Reiss, GR, Mohiuddin, MM, Blankenhorn, EP, DiSesa, VJ. “Use of the Polymerase Chain Reaction (PCR) to Detect Microchimerism after Intrathymic Injection in Experimental Heart Transplantation.” The Society of University Surgeons 39th Annual University Surgical Residents’ Conference, Tampa, FL, 1997.
6. - Mohiuddin MM, Reiss GR, DiSesa VJ. “Effect of Fetal and Neonatal Injection of Donor Fetal cells and Skin Grafts on Hamster to Rat Cardiac Xenograft Survival.” The 4th International Congress for Xenotransplantation, Nantes, France, 1997.
7. - Langell, JT, Reiss, GR, Cramer, DV, Blankenhorn, EP, Kresh, JY. “Mycophenolic Acid and 3-Azido-3-Deoxythimadine Decrease Expression of the α-1,3-Galactosyl Carbohydrate on Porcine Endothelial Cells.” The 4th International Congress for Xenotransplantation, Nantes, France, 1997.
8. - Reiss, GR, Mohiuddin, MM, DiSesa, VJ. “PCR to Detect Microchimerism in Experimental Heart Transplantation with Intrathymic Pretreatment: Evidence that Donor Cells Do Not Re-enter the Thymus.” The American College of Surgeons 83rd Annual Clinical Congress, Chicago, IL, 1997.
9. - Langell, JT, Reiss, GR, Strong, J, Kresh, JY, Blankenhorn, EP. “Suppression of the α-1,3-Galactosyl Epitope by Golgi Expression of a Coffee Bean α-1,3-Galactosidase Transgene.” American Society of Transplant Physicians 17th Annual Scientific Meeting, Chicago, IL, 1998.
10. - Langell, JT, Reiss, GR, BlankenhornEP, Kresh, JY. “3-Azido-3-Deoxythymidine Decreases Cell Surface Expression of the α-1,3-Galactosyl Carbohydrate on Porcine Endothelial Cells.” American Society of Transplant Physicians 17th Annual Scientific Meeting, Chicago, IL, 1998.
11. - Langell, JT, Reiss, GR, DiSesa, VJ. “Antisense Ribozyme Degradation of α-1,3-Galactosyltransferase mRNA: a possible mechanism for reduction of α-1,3Gal.” American Society of Transplant Surgeons 24th Annual Scientific Meeting, Chicago, IL, 1998.
12. - Mohiuddin, MM, Yokoyama, H, Reiss, GR, DiSesa, VJ. “Induction of Tolerance to an ‘Untolerizable’ Strain by Double-Strain Intrathymic Inoculation in Experimental Rat Cardiac Transplantation.” The Transplantation Society, XVII World Congress, Montreal, Canada, 1998.
13. - Reiss, GR, Langell, JT, Mohiuddin, MM, DiSesa, VJ, Prockop, DJ. “Rescue from Lethal Total Body Irradiation by Allogenic Marrow Stromal Cells.” The American College of Surgeons 84th Annual Clinical Congress, Orlando, FL, 1998.
14. - Choi, D, Lee, M, Bull, DA, Reiss, GR, Chang, C, Christensen, L, Kim, SW. Hypoxia-Inducible VEGF Gene Therapy Using the RTP801 Promoter. The American Society of Gene Therapy 7th Annual Meeting, Minneapolis, MN, 2004.
15. - Whitten, MG, Reiss, GR, Choi, D, Lee, M, Kim, SW, Bull, DA. Ischemia-Iinducible Gene Therapy for Myocardial Infarction. Western Thoracic Surgery Association, Victoria, BC, 2005.
16. – Toegel, FE, Hu, P, Hu, Z, Yang, Y, Reiss, GR, Westenfelder, C. Development of a highly sensitive, in vivo Bioluminescence Assay to investigate the Homing and Distribution of administered Mesenchymal Stem Cells (MSC) in Acute Kidney Injury (AKI). American Society of Nephrology, San Diego, CA, 2006.
17. – Connors, RC, Muir, JJ, Reiss, GR, Whitten, MG, Sorenson, TK, Albanil, A, Liu, Y, Prestwich, GD, Bull, DA. Postoperative Pericardial Adhesion Prevention using CARBYLANTM-SX in a rabbit model. 2nd Academic Surgical Congress, Phoenix, AZ, February 2007.
18. – Reiss, GR, Williams, MR. Simultaneous Hybrid Revascularization. New York Society of Thoracic Surgeons. New York, NY, February 2011.
19. - Elia, R, Newhide, DR, Pedevillano, PD, Reiss, GR, Firpo, MA, Hsu, EW, Kaplan, DL, Prestwich, GD, and Peattie, RA. A Novel Securable Hyaluronic Acid-Silk Hydrogel Composite for Controlled Drug Release. Biomedical Engineering Society, Hartford, CT, October 2011.
20. - Reiss, GR. Essential Review of the Data: Hybrid Revascularization. 20th Annual Cardiovascular Nurse and Technologist Symposium. Transcatheter Cardiovascular Therapies (TCT) San Francisco, CA, November 7, 2011.
21. - Reiss, GR, Williams, MR. Trans-Apical Closure of Perivalvular Leaks. TCT, San Francisco, CA, November 9, 2011.
Abstracts:
1. - Goldstein C, Reiss GR, Yokoyama H, Shen Z, Muhiuddin M, DiSesa VJ. A Clinically Applicable Intrathymic Pretreatment Regimen Produces Tolerance to Experimental Cardiac Transplants. Surgical Forum, 1996;47:245.
2. - Langell, JT, Reiss, GR, Cramer, DV, Blankenhorn, EP, Kresh, JY. Mycophenolic Acid and 3-Azido-3-Deoxythymidine Decrease Expression of the α-1,3-Galactosyl Carbohydrate on Porcine Endothelial Cells. The 4th International Congress for Xenotransplantation 1997, Book of Abstracts: O24.
3. - Mohiuddin, MM, Reiss, GR, DiSesa, VJ. Effect of Fetal and Neonatal Injection of Donor Fetal cells and Skin Grafts on Hamster to Rat Cardiac Xenograft Survival. The 4th International Congress for Xenotransplantation 1997, Book of Abstracts: P276.
4. - Reiss, GR, Mohiuddin, MM, DiSesa, VJ. PCR to Detect Microchimerism in Experimental Heart Transplantation with Intrathymic Pretreatment: Evidence that Donor Cells Do Not Re-enter the Thymus. Surgical Forum, 1997; 48:505-508.
5. - Langell, JT, Reiss, GR, Strong, J, Kresh, JY, Blankenhorn, EP. Suppression of the α-1,3-Galactosyl Epitope by Golgi Expression of a Coffee Bean α-1,3-Galactosidase Transgene. Transplantation, 1998; 65 (12):S184.
6. - Langell, JT, Reiss, GR, Cramer, DV, BlankenhornEP, Kresh, JY. 3-Azido-3-Deoxythymidine Decreases Cell Surface Expression of the α-1,3-Galactosyl Carbohydrate on Porcine Endothelial Cells. Transplantation, 1998; 65 (12):S184.
7. - Langell, JT, Reiss, GR, DiSesa, VJ. Antisense Ribozyme-Mediated Cleavage of α-1,3-Galactosyltransferase mRNA: a mechanism for reduction of the α-1,3-Galactosyl EpitopeTransplantation, 1998; 66(8):S27.
8. - Langell, JT, Reiss, GR, DiSesa, VJ. Antisense Ribozyme Degradation of α-1,3-Galactosyltransferase mRNA: a possible mechanism for reduction of α-1,3Gal. American Society of Transplant Surgeons 24th Annual Scientific Meeting Program, 1998; 105.
9. - Reiss, GR, Langell, JT, Mohiuddin, MM, DiSesa, VJ, Prockop, DJ. Rescue from Lethal Total Body Irradiation by Allogenic Marrow Stromal Cells. Surgical Forum, 1998; 49:392-394.
10. - Choi, D, Lee, M, Bull, DA, Reiss, GR, Chang, C, Christensen, L, Kim, SW. Hypoxia-Inducible VEGF Gene Therapy Using the RTP801 Promoter. Molecular Therapy, 2004.
Book Chapters:
1. - Reiss, GR, “General Surgery: Experimental Work”, in Ocular Applications of the Fugo Blade. Roy, H et al., eds. Lippincott Williams & Wilkins, 2010.
2. - Reiss, GR, Williams, MR, “Role of the Cardiac Surgeon”, in Interventional Cardiology 6th Edition, Topol and Tierstien, eds. Elsevier, 2011.
3. - Reiss, GR, Williams, MR, “Hybrid treatments and future perspectives”, in Coronary Atherosclerosis: Current Management and Treatment, 1st Edition. Arampatzis, C, et al. Informa, 2012.
4. - George, I, Reiss, GR, Williams, MR, “Transcatheter Aortic Valve Replacement”, in Mastery of Cardiothoracic Surgery 3rd Edition. Kaiser, Kron, and Spray, eds. 2013.
5. - Reiss, GR, Williams, MR, “Role of the Cardiac Surgeon”, in Interventional Cardiology 7th Edition, Topol and Tierstien, eds. Elsevier, 2015.
Publications:
1. - Shen Z, Muhiuddin M, Yokoyama H, Reiss GR, DiSesa VJ. Induction of Tolerance to an Experimental Cardiac Allograft Requires Inoculation of Class II MHC Disparate Antigens. J Thorac Cardiovasc Surg, 1996; 112:1315-1318.
2. - Shen Z, Pelletier S, Muhiuddin MM, Yokoyama H, Reiss GR, DiSesa VJ. Different Immune Effects On Cardiac Allografts and Xenografts Induced by Neonatal Intrathymic Inoculation with Allo- and Xenogeneic Antigens. J Heart & Lung Trans, 1996; 15(10): 1034-1038.
3. - Goldstein C, Reiss GR, Yokoyama H, Shen Z, Muhiuddin MM, DiSesa VJ. Tolerance to Experimental Cardiac Allografts Requires a Time Lag Between Intrathymic Pretreatment and Transplantation. J Surgical Research, 1996; 63(1): 83-85.
4. - Mohiuddin MM, Yokoyama H, Reiss GR, DiSesa VJ. Induction of Tolerance to an "Untolerizable" Strain by Double-Strain Intrathymic Inoculation in Experimental Rat Cardiac Transplantation. Transplantation Proceedings. 1999; 31(1-2): 838-9.
5. - Emerson L, Layfield LJ, Reiss R, Mulvihill S, Holden J. Malignant Islet Cell Tumor with Sarcomatous Differentiation. Mod Pathol 2001 Nov; 14(11): 1187-91.
6. - Connors RC, Muir JJ, Reiss GR, Liu Y, Kouretas PC, Whitten MG, Sorenson TK, Prestwich GD, Bull DA. Postoperative Pericardial Adhesion Prevention Using CARBYLANTM-SX in a Rabbit Model. J Surgical Research, 2007; 140,237-42.
7. - Gooch A, Doty J, Flores J, Swenson L, Toegel F, Reiss GR, Lange C, Zander AR, Hu Z, Yang P, Poole S, Westenfelder C. Initial Report on a Phase I Clinical Trial: Prevention and Treatment of Post-operative Acute Kidney Injury with Allogeneic Mesenchymal Stem Cells in Patients Who Require On-Pump Cardiac Surgery. Cell Therap and Transplant. 2008; Vol. 1, No. 2, 24 Dec; 31-35.
8. - Balter, S, Zanaonico, P, Reiss, GR, Moses, JW. Radiation is Not the Only Risk. Am J Roentgenol. 2011 April; (196): 762-67.
9. - Genereux, P, Kodali, S, Leon, MB, Smith, CR, Kirtane, AJ, Ben-Gal, Y, Daneault, B, Reiss, GR, Moses, JW, Williams, MR. Clinical Outcomes Using a New Crossover Balloon Occlusion Technique for Percutaneous Closure After Transfemoral Aortic Valve Implantation. J Am Coll Cardiol Intv 2011, 4:861-7.
10. – Reiss, GR, Smith, CR. PARTNER B: Where will it take us? Semin Thorac Cardiovac Surg 2011, Vol. 23, 2:85-86.
11. - Daneault, B, Kirtane, AJ, Kodali, SK, Williams, MR, Généreux, P, Reiss, GR, Smith, CR, Moses, JW, Leon, MB. Stroke Associated with Treatment of Aortic Stenosis: A Comprehensive Review. J Am Coll Cardiol 2011, vol. 58 (21) 2143-50.
12. - Généreux, P, Reiss, GR, Kodali, SK, Williams, MR, Daneault, B, McEntegart, M, Moses, JW, Smith, CR, Leon, MB, Hahn, RT. Peri-aortic Hematoma after Trans-catheter Aortic Valve Replacement (TAVR): Description of a new complication. Catheter Cardiovasc Interv. 2012 Apr 1;79(5):766-76.
13. - Daneault, B, Balter, S, Kodali, SK, Williams, MR, Généreux, P, Kirtane, AJ, Reiss, GR, Green, P, Smith, CR, Moses, JW, Leon, MB. Radiation Exposure During Transcatheter Aortic Valve Replacement Procedures. EuroIntervention. 2012 Oct 22;8(6):679-84.
14. – Elia, RE, Newhide, DR, Pedevillano, PD, Reiss, GR. Firpo, MA, Hsu. EW, Kaplan, DL, Prestwich, GW, Peattie, RA. Silk-Hyaluronan-based Composite Hydrogels: a Novel, Securable Vehicle for Drug Delivery. J Biomater Appl 2013, Feb;27(6):749-62.
15. - Daneault, B, Koss, E, Hahn, R, Kodali, SK, Williams, MR, Généreux, P, Paradis, J, George, I, Reiss, GR, Moses, JW, Smith, CR, Leon, MB. Efficacy and Safety of Post-Dilatation to Reduce Paravalvular Regurgitation During Balloon-Expandable Transcatheter Aortic Valve Replacement. Circ Cardiovasc Interv, 2013, Feb;6(1):85-91.
16. - Svensson, LG, Adams, DH, Bonow, RO, Kouchoukos, NT, Miller, DC, O’Gara, PT, Shahian, DM, Schaff, HV, Akins, CW, Baveria, J, Blackstone, EH, David, TE, Desai, ND, Dewey, T, D’Agostino, RS, Gleason, T, Harrington, KB, Kodali, S, Kapadia, S, Leon, M, Lima, B, Lytle, BW, Mack, MJ, Reece, TB, Reiss, GR, Roselli, E, Smith, CR, Thourani, VH, Tuzcu, EM, Webb, J, Williams, MR. Aortic Valve and Ascending Aorta Guidelines for Management and Quality Measures: Executive Summary. Ann Thorac Surg. 2013, Apr;95(4):1491-505
17. - Ertelt K, Généreux P, Mintz GS, Reiss GR, Kirtane AJ, Madhavan MV, Fahy M, Williams MR, Brener SJ, Mehran R, Stone GW. Impact of the Severity of Coronary Artery Calcification on Clinical Events in Patients Undergoing Coronary Artery Bypass Grafting (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial). Am J Cardiol. 2013, Dec 1;112(11):1730-7
18 - Généreux P, Bernard S, Palmerini T, Caixeta A, Rosner G, Reiss GR, Xu K, Mehran R, Stone GW. Incidence, predictors, and impact of neurological events in non-ST-segment elevation acute coronary syndromes: the ACUITY trial. EuroIntervention. 2015 Aug;11(4):399-406.
Professional Interests:
Sports Science & Human Performance
Cell Therapy and Regenerative Medicine
Life Science and Medical Device Commercialization
Adult Cardiac Surgery, Interventional Cardiology & Transcatheter Valve Therapies
Personal Interests:
Skiing, Dirt & Mountain Biking, Camping, Fly Fishing, Music
